Show simple item record

dc.contributor.authorBlockman, M.
dc.contributor.authorCohen, K.
dc.contributor.authorDe Waal, R.
dc.contributor.authorGray, A.
dc.contributor.authorKredo, T.
dc.contributor.authorMaartens, G.
dc.contributor.authorNel, J.
dc.contributor.authorParrish, A.
dc.contributor.authorRees, H.
dc.date.accessioned2020-07-20T09:01:00Z
dc.date.available2020-07-20T09:01:00Z
dc.date.issued2020-06-18
dc.identifier.citationBoulware DR, Pullen MF,  Bangdiwala AS, Pastick KA,  Lofgren SM, Okafor EC, et  al. A Randomized Trial of  Hydroxychloroquine as  Postexposure Prophylaxis  for Covid‐19. New England  Journal of Medicine. 2020.en_US
dc.identifier.urihttps://infospace.mrc.ac.za/handle/11288/595264
dc.language.isoenen_US
dc.publisherSouth African National Department of Healthen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleChloroquine and hydroxychloroquine for prevention of COVID‐19: evidence review of clinical benefits and harmen_US
dc.typeOtheren_US
dc.contributor.departmentSD and TK (Cochrane South Africa, South  African Medical Research Council, SA GRADE Network), MB (Division of Clinical Pharmacology, Department of Medicine,  Groote Schuur Hospital, University of Cape Town)en_US
dc.research.unitSouth African Cochrane Centreen_US
dc.date.epub2020-06-18


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States